Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Akero Therapeutics, Inc. | 3,227,767 | reported | 27 Feb 2020 | tx 6−15,930 |
| Checkmate Pharmaceuticals, Inc. | 2,995,859 | reported | 26 Apr 2022 | tx 3−129,781 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Apr 2022 | SALE | Checkmate Pharmaceuticals, Inc. | 64,683 | 10.38 USD | |
| 22 Apr 2022 | SALE | Checkmate Pharmaceuticals, Inc. | 37,430 | 10.39 USD | |
| 25 Apr 2022 | SALE | Checkmate Pharmaceuticals, Inc. | 27,668 | 10.39 USD | |
| 25 Feb 2020 | SALE | Akero Therapeutics, Inc. | 1,600 | 23.67 USD | |
| 27 Feb 2020 | SALE | Akero Therapeutics, Inc. | 1,781 | 22.54 USD | |
| 26 Feb 2020 | SALE | Akero Therapeutics, Inc. | 2,523 | 22.44 USD | |
| 11 Feb 2020 | SALE | Akero Therapeutics, Inc. | 2,184 | 27.05 USD | |
| 12 Feb 2020 | SALE | Akero Therapeutics, Inc. | 6 | 27.14 USD | |
| 10 Feb 2020 | SALE | Akero Therapeutics, Inc. | 7,836 | 27.08 USD |